Venus Concept Inc. (VERO)
NASDAQ: VERO · Real-Time Price · USD
0.303
-0.009 (-2.88%)
At close: Nov 20, 2024, 4:00 PM
0.296
-0.007 (-2.31%)
Pre-market: Nov 21, 2024, 7:15 AM EST
Venus Concept Employees
Venus Concept had 304 employees as of December 31, 2023. The number of employees decreased by 80 or -20.83% compared to the previous year.
Employees
304
Change (1Y)
-80
Growth (1Y)
-20.83%
Revenue / Employee
$221,053
Profits / Employee
-$164,957
Market Cap
2.20M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Xylo Technologies | 84 |
Scorpius Holdings | 84 |
Fresh2 Group | 75 |
Scinai Immunotherapeutics | 31 |
Biodexa Pharmaceuticals | 21 |
HeartSciences | 15 |
Phio Pharmaceuticals | 9 |
180 Life Sciences | 4 |
VERO News
- 7 days ago - Venus Concept Inc. (VERO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Venus Concept Announces Third Quarter of Fiscal Year 2024 Financial Results - GlobeNewsWire
- 14 days ago - Venus Concept Announces Expansion of International Distribution Network and Certification of Products in India - GlobeNewsWire
- 7 weeks ago - Venus Concept to Release Third Quarter of Fiscal Year 2024 Financial Results on November 13, 2024 - GlobeNewsWire
- 7 weeks ago - Venus Concept Announces $15 million Debt-to-Equity Exchange Transaction - GlobeNewsWire
- 2 months ago - Venus Concept Announces Australian Regulatory Approval for Venus Bliss MAX - GlobeNewsWire
- 3 months ago - Venus Concept Inc. (VERO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Venus Concept Announces Second Quarter of Fiscal Year 2024 Financial Results - GlobeNewsWire